May 2, 2022
Life Sciences
  • The Food and Drug Administration (FDA) announced Friday it will hold meetings in June for its key advisory committee to discuss the Moderna and Pfizer-BioNTech requests for emergency authorization for kids five and under. The announcement was made one day after Biden administration officials indicated they would prefer the FDA evaluate data and simultaneously make decisions about how Moderna and Pfizer-BioNTech’s vaccines work on small children, to give parents more of a comparison, which could take as long as June. Moderna Chief Medical Officer Paul Burton said on Sunday the company’s vaccine for children will be ready for review in June and that the company was preparing to provide large amounts of its vaccine booster against omicron and other COVID-19 variants this fall. (Announcement here; Articles here, here, here, and here)